ANNEE 2014

Publié le 17/03/2015 à 12h15 (mis à jour le 31/08/2015 à 16h06)


Bruzzone A, Saulière A, Finana F, Sénard JM, Lüthy I, Galés C. Dosage-dependent regulation of cell proliferation and adhesion through dual beta2-AR)/cAMP signals. FASEB J 2014 ;28(3):1342-54.

Dague E, Genet G, Lachaize V, Guilbeau-Frugier C, Fauconnier J, Mias C, Payré B, Chopinet L, Alsteens D, Kasas S, Severac C, Thireau J, Heymes C, Honton B, Lacampagne A, Pathak A, Sénard JM, Galés C. Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure. J Mol Cell Cardiol. 2014 Sep ;74:162-72.

Gargiulo L, Copsel S, Rivero EM, Galès C, Sénard JM, Luthy IA, Davio C, Bruzzone A. Differential B2-adrenergic receptor defines the phenotype of non-tumorigenic and malignant human breast cell lines. Oncotarget.
2014 ;5:1058-69.


Palfi S, Gurruchaga JM, Scott G, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S, Iwamuro H, Lefauchgeur JP, Thiriez C, Fenelon G, Lucas C, Brugières P, Gabriel I, Abhay K, Drouot X, Tani N, Kas A, Ghaleh B, Le Corvoisier P, Dolphin P, Breen DP, Mason S, Valle Guzman N, Mazarakis ND, Radcliffe PA, Harrop R, Kingsman SM, Rascol O, Naylor S, Barker RA, Hantraye P, Remy P, Cesaro P, Mitrophanous KA. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkonson’s disease : a dose escalation, open-label, phase 1/2 trial. Lancet. 2014 ;383:1138-46.

Hauser RA, Gordon MF, Mizuno Y, Poewe W, Barone P, Schapira A, Rascol O, Debieuvre C, Fräßdorf M. Minimal clinically important difference in Parkinson’s disease as assessed in pivotal trials of Pramipexole extended release. Parkinson’s Disease. 2014 ;467131:1-8.

Hauser RA, Schapira AH, Barone P, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe M. Pramipexole ER Studies Group. Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson’s disease. Eur J Neurol. 2014 ;21:736-43.

Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O, Ns-Park CIC Network. Withdrawing chronic amantadine therapy in dyskinetic patients with Parkinson disease : the AMANDYSK trial. Neurology. 2014 ;82:300-7.

Ory-Magne F, Rascol O. Author response. Neurology. 2014 Sep 9 ;83(11):1036.

Ory Magne F, Arcari C, Canivet C, Sarrail M, Fabre MH, Mohara C, Brefel Courbon C. A therapeutic educational program in Parkinson’s disease : ETPARK. Rev Neurol (Paris). 2014 Feb ;170(2):128-33.

Ory Magne F, Fabre N, Gu C, Pastorelli C, Tardez S, Marchat JC, Marque P, Brefel Courbon C. An individual rehabilitation program : Evaluation by Parkinsonian patients and their physiotherapists. Rev Neurol (Paris). 2014 Nov ;170(11):680-4.

Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner W, Schelosky L, Tison F, Rascol O. Prevalence, determinants, and effect on Quality of Life of Freezing of Gait in Parkinson’s Disease. JAMA Neurol. 2014 ;71:884-90.

Perez-Lloret S, Rey MV, Crispo J, Krewski D, Lapeyre-Mestre M, Montastruc JL, Rascol O. Risk of heart failure following treatment with dopamine agonists in Parkinson’s disease patients. Expert Opin Drug Saf.
2014 ;13:351-60.

Perez-Lloret S, Rey MV, Pavy-Le Traon A, Rascol O. Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders. Expert Opinion on Orphan Drugs. 2014 ;2:509-22.

Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Ruzicka E, McCrone P, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A. Measurement of costs and scales for outcome evaluation in health Eeconomic studies of patients with Parkinson’s Disease. Mov Disord. 2014 ;29:169-76.

Rascol O. Jejunal levodopa infusion in Parkinson’s disease. Lancet Neurol. 2014 ;13:128-29.

Rascol O, Fox S, Gasparini F, Kenney C, Di Paolo T, Gomez-Mancilla B. Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias : Parkinsonism Relat Disord. 2014
Sep ;20(9):947-56.

Rascol O. Can a new trial end controversy over when to use levodopa ? Nature Reviews Neurology. -2014 Sep ;10(9):488-9.

Rascol O, Stocchi F, Isaacson S, Ondo W. Apomorphine penject - emerging evidence and treatment strategies for delayed ON and OFF periods in Parkinson’s disease. EMJ Neurol. 2014 ;1:27-35.

Rey MV, Perez-Lloret S, Pavy le Traon A, Meissner WG, Tison F, Rascol O. A cross-sectional study on drug use in multiple system atrophy. CNS Drugs. 2014 ;28:483-90.

Yousfi M, Merbahi N, Pathak A, Eichwald O. Low-temperature plasmas at atmospheric pressure : toward new pharmaceutical treatments in medicine. Fundam and Clin Pharmacol. 2014 ;28:123-35.

Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis K, Ukena C, Zeller T. From SYMPLICITY HTN-3 to the Renal Denervation Global Registry : where do we stand and where should we go ? EuroIntervention. 2014 ;10:21-3.

Pathak A, Morel C, Honton B, Fajadet J, Galinier M, Senard JM.  Bursting of the renal denervation bubble ? La lettre du Cardiologue. 2014 Sept ;477:31.

Honton B, Pathak A, Sauguet A Fajadet J. First report of transradial renal denervation with the dedicated radiofrequency iberis catheter. EuroIntervention. 2014 ;9:1385-8.

Vaccaro A, Despas F, Delmas C, Lairez O, Lambert E, Lambert G, Labrunée M, Guiraud T, Esler M, Galinier M, Senard JM, Pathak A. Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. Plos One. 2014 ;DOI : 10.137.

Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, Girerd X ; French Society of Hypertension. Management of hypertension in adults : the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol. 2014 Feb ;28(1):1-9.

Dobre D, Borer JS, Fox K, Swedberg K, Adams KF, Cleland JG, Cohen-Solal A, Gheorghiade M, Gueyffier F, O’Connor CM, Fiuzat M, Patak A, Piña IL, Rosano G, Sabbah HN, Tavazzi L, Zannad F. Heart rate : a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. Eur J Heart Fail. 2014 ;16:76-85.

Pellaprat J, Ory-Magne F, Canivet C, Simonetta-Moreau M, Lotterie JA, Radji F, Arbus C, Gerdelat A, Chaynes P, Brefel-Courbon C. Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson’s disease. Parkinsonism Relat Disord. 2014 Jun ;20(6):662-4.

Fernagut PO, Dehay B, Maillard A, Bezard E, Perez P, Traon A, Rascol O, Foubert-Samier A, Tison F, Meissner W. Multiple system atrophy : A prototypical synucleinopathy for disease-modifying therapeutic strategies. Neurobiol Dis. 2014 ;67:133-9.

Bezard E, Pioli EY, Li Q, Girard F, Mutel V, Keywood C, Tison F, Rascol O, Poli SM.  The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model. Mov Disord. 2014 ;8:1074-79.

Senard JM. L’hypotension orthostatique neurogène et ses traitements. Neurone. 2014 ;19:45-50.


Molinier A, Acket B, Bourrel R, Lavezzi O, Montastruc JL, Bagheri H. Extrapolation des données physiopathologiques à la pratique clinique : à propos du dabigatran utilisé hors AMM. Press Med. 2014 ;43:468-9.

Bounes V, Jouanjus E, Roussin A, Lapeyre-Mestre M. Acute pain management for patients under opioid maintenance treatment : what physicians do in emergency departments ? Eur J Emerg Med. 2014 Feb ;21(1):73-6.

Petchy MF, Bounes V, Dehours E, Moulie L, Edlow JA. Characteristics of patients with acute ischemic stroke intubated before imaging. Eur J Emerg Med. 2014 Apr ;21(2):145-7.

Cottron N, Larcher C, Sommet A, Fesseau R, Alacoque X, Minville V, Fourcade O, Kern D. The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants : a bench test study. Anesth Analg. 2014 ;119:67-75.

Fuzier R, Serres I, Bourrel R, Palmaro A, Montastruc JL, Lapeyre-Mestre M. Analgesic drug consumption increases after knee arthroplasty : a pharmacoepidemiological study investigating postoperative pain. Pain. 2014 ;155:1339-45.

Fuzier R, Lapeyre-Mestre M. Factors affecting chronic pain and increases of analgesic drug consumption after knee arthroplasty : Reply. Pain. 2014 Dec ;155(12):2721-2.

Dehours E, Bounes V, Bagheri H, Valle B, Ducassé JL, Montastruc JL. Adverse drug reactions in an emergency medical dispatching centre. Eur J Clin Pharmacol. 2014 ;70:881-7.

Lapeyre-Mestre M, Gony M, Carvajal A, Macias D, Conforti A, D’Incau P, Heerdink R, Van der Stichele R, Bergman U. A European Community Pharmacy-Based Survey to Investigate Patterns of Prescription Fraud through Identification of Falsified Prescriptions. Eur Addict Res. 2014 ;20(4):174-82.

Lapeyre-Mestre M. Médicaments sans ordonnance : du mésusage à la dépendance. Sciences médicale, Paul Sabatier. 2014 Jan:25.

Dupouy J, Mémier V, Catala H, Lavit M, Oustric S, Lapeyre-Mestre M. Does urine drug abuse screening help for managing patients ? A systematic review. Drug Alcohol Depend. 2014 Mar 1 ;136:11-20.

Dupouy J, Fournier JP, Jouanjus É, Palmaro A, Poutrain JC, Oustric S, Lapeyre-Mestre M. Baclofen for alcohol dependence in France : incidence of treated patients and prescription patterns—a cohort study. Eur Neuropsychopharmacol. 2014 Feb ;24(2):192-9.

Jouanjus E, Lapeyre-Mestre M, Micallef J. Cannabis use : signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014 ;3:e000638 doi : 10.1161/JAHA.113.000638.

Vrignaud L, Aouille J, Mallaret M, Durrieu G, Jonville-Béra AP. Hypersexualité induite par l’aripiprazole : à propose d’un cas et revue de la littérature. Thérapie. 2014 ;69(6):525-27.

Saliba L, Boisson L, Sallerin B, Laroche M, Despas F. Défaut d’observance aux médicaments antiostéoporotiques : croisement de deux techniques, la clef pour l’évaluation de l’observance ? Thérapie. 2014 ;69:383-9.

Birebent J, Dupouy J, Bismuth M, Magnaval V, Despas F, Alquier V, Oustric S. La mention "non substituable" de la prescription à la délivrance : comparaison des points de vue des médecins généralistes libéraux et des pharmaciens d’officine de la région Midi-Pyrénées. Thérapie. 2014 ;69:401-17.

Montastruc F, Montastruc G, Taudou MJ, Olivier-Abbal P, Montastruc JL, Bondon-Guitton E. Acute coronary syndrome after nasal spray of oxymetazoline. Chest. 2014 Dec 1 ;146(6):e214-5.

Montastruc F, Retailleau, Rousseau V, Bagheri H, Montastruc JL. Atropinic burden of prescription forms in France : a study in community pharmacies in 2013. Eur J Clin Pharmacol. 2014 ;70:1147-48.

Montastruc F, Duguet C, Rousseau V, Bagheri H, Montastruc JL. Potentially inappropriate medications and adverse drug reactions in the elderly : a study in a pharmacovigilance database. Eur J Clin Pharmacol. 2014 ;70:1123-27.

Montastruc F, Scotto S, Vaz IR, Guerra LN, Escudero A, Sáinz M, Falomir T, Bagheri H, Herdeiro MT, Venegoni M, Montastruc JL, Carvajal A. Hepatotoxicity related to agomelatine and other new antidepressants : a case/noncase approach with information from the portuguese, French, spanish, and italian pharmacovigilance systems. J Clin Psychopharmacol. 2014 ;34:327-30.

Montastruc F, Moulis G, Palmaro A, Gardette V, Durrieu G, Montastruc JL. Interactions between Medical Residents and Drug Companies : A National Survey after the Mediator® Affair. PLoS One. 2014 Oct 3 ;9(10):e104828.

Montastruc JL. Statines : précisions. Rev Med Suisse. 2014 ;10:1089.

Montastruc P. Histoire de la pharmacologie clinique en France : dans une scintillante introspective, l’adaptation, l’évaluation, la défense et l’illustration du médicament en France 1978-1981. Thérapie. 2014 ;69:481-2.

Moulis G, Sailler L, Adoue D, Lapeyre-Mestre M. Pharmacoepidemiology of immune thromobocytopenia : protocols of FAITH and CARMEN studies. Pharmacoepidemiol. 2014 ;69:437-48.

Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailer L. Epidemiology of incident immune thrombocytopenia : a nationwide population-based study in France. Blood 2014 ;124:3308-15.

Moulis G, Sommet A, Lapeyre-Mestre M, Montastruc JL ; on behalf of the Association Française des Centres Régionaux de PharmacoVigilance. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor ? A case/non-case study in a nationwide pharmacovigilance database. Rheumatology.
2014 ;53:1864-71.

Moulis G, Bagheri H, Sailler L, Jonville-Bera AP, Weber E, Guy C, Petitpain N, Laroche ML, Favrelière S, Béné J, Baldin B, Villeval-Federici L, Tebacher-Alt M, Bres V, Veyrac G, Grandvuillemin A, The French Association of PharmacoVigilance Centers. Are adverse drug reaction patterns different between romiplostim and eltrombopag ? 2009-2013 French Pharmacovigilance assessment. Eur J Int Med. 2014 ;25:777-80.

Moulis G, Sommet A. How to read a meta-analysis ? Rev Med Interne. 2014 Apr ;35(4):250-8.

Moulis G, Sailler L, Bonneville F, Wagner T. Imaging in Erdheim-Chester disease : classic features and new insights. Clin Exp Rheumatol. 2014 May-Jun ;32(3):410-4.

Moulis G, Sailler L, Sommet A, Lapeyre-Mestre M, Derumeaux H, Adoue D. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia : an adjusted comparison of mortality and morbidity. Am J Hematol. 2014 Jan ;89(1):41-6.

Mouly C, Hanaire H, Sénard JM, Gerdelat A, Pavy-LeTraon A. Sudoscan : Intérêt en pratique Clinique. Diabète & Obésité • 2014 ; 9 (81) : 2-5.

Abou Taam M, Rossard C, Cantaloube L, Bouscaren N, Roche G, Pochard L, Montastruc F, Herxheimert A, Montastruc JL, Bagheri H. Analysis of patients narratives posted on social media websites on benfluorex’s (Mediator) withdrawal in France. J of Clin Pharmacy and Therapeutics. 2014 ; 39:53-5.

Allavena C, Jacomet C, Pereira B, Morand-Joubert L, Bagheri H, Cotte L, Garaffo R, Gerbaud L, Dellamonica P. Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France. J Int AIDS Soc. 2014 Nov 2 ;17(4 Suppl 3):19608.

Béné J, Moulis G, Auffret M, Lefevre G, Coquerelle P, Coupe P, Péré P, Gautier S. Alopecia induced by tumour necrosis factor-alpha antagonists : description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database. Rheumatology (Oxford). 2014 ;53:1465-9.

Bondon-Guitton E. Pharmacogénétique en pratique. In CD du 26e Forum de la Faculté de Médecine Toulouse Rangueil et Purpan le 26 octobre 2014.

Cool C, Cestac P, Laborde C, Lebaudy C, Rouch L, Lepage L, Vellas B, de Souto Barreto P, Rolland Y, Lapeyre-Mestre M. Potentially inappropriate drug prescribing and associated factors in nursing homes. J Am Med Dir Assoc. 2014 ;15(11):850.e1-9.

Courrier V, Fournier JP, Sommet A, Montastruc JL, Poutrain JC. Parenteral anticoagulants use in general practice : a cross-sectional study in south western France. Clin Appl Thrombosis. 2014, DOI : 10.1177/1076029614548057.

D’Incau P, Lapeyre-Mestre M, Carjaval A, Donati M, Salado I, Rodriguez L, Sainz M, Escudero A, Conforti A. No difference between men and women in adverse drug reactions related to psychotropic drugs : a survey from France, Italy and Spain. Fundam and Clin Pharmacol. 2014 ;28:342-348.

Durrieu G, Batz A, Rousseau V, Bondon-Guitton E, Petiot D, Montastruc JL. Use of administrative database to identify adverse drug reactions in a pediatric university hospital. Eur J Clin Pharmacol. 2014 ;70:1519-26.

Elghozi JL, Senard JM. Prise en charge de l’hypotension orthostatique. Arch Mal Cœur 2014 ; 232:14-22.

Eschalier A, Montastruc JL. Hommage au professeur Pierre DUCHÊNE-MARULLAZ (1921-2014). Therapie. 2014 Nov-Dec ;69(6):479.

Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL. More on the « triple whammy » : antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury – a case/non-case study in the french pharmacovigilance database. Ren Fail. 2014 Aug ;36(7):1166-8.

Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents : a descriptive study using the French pharmacovigilance database. Fundam and Clin Pharmacol. 2014 ;28:230-5.

Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V. Trends in use of antipsychotics in elderly patients with dementia : Impact of national safety warnings. Eur Neuropsychopharmacol. 2014 Jan ;24(1):95-104.

Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S. A 2-year prospective cohort studuy of antidementia drug non-persistency in mild-to-moderate Alzheimer’s disease in Europe : predictors of discontinuation and switch in the ICTUS study. CNS Drugs. 2014 ;28:157-70.

Goodacre S, Stevens JW, Pandor A, Poku E, Ren S, Cantrell A, Bounes V, Mas A, Payen D, Petrie D, Roessler MS, Weitz G, Ducros L, Plaisance P. Prehospital noninvasive ventilation for acute respiratory failure : systematic review, network meta-analysis, and individual patient data meta-analysis. Acad Emerg Med. 2014 Sep ;21(9):960-70.

Hein C, Forgues A, Piau A, Sommet A, Nourhashémi F, Vellas B. Impact of polypharmacy on occurrence of delirium in elderly emergency patients. J Am Med Dir Assoc. 2014 ;15(11):850.e11-5.

Honton B, Despas F, Dumonteil N, Rouvellat C,Roussel M, Carrie D, Galinier M, Montastruc JL. Bortezomib and heart failure : case-report and review of the French Pharmacovigilance database. Fundam Clin Pharmacol. 2014 ;28:349-52.

Jacquot J, Bagheri H, Montastruc JL. La notification d’effet indésirable au secours de l’ordonnance « non substituable » ! Thérapie. 2014 ;69:259-61.

Laffont MA, Sommet A, Alvarez M, Bruyand M, Bonnet J, Marchou B, Delobel P. A-10 : Complications infectieuses des lymphomes liés au VIH pris en charge par une association rituximab-polychimiothérapie. Med Mal Infect. 2014 Jun ;44(6 Suppl):21.

Lauque D, Maupas-Schwalm F, Bounes V, Juchet H, Bongard V, Roshdy A, Botella JM, Charpentier S. Predictive value of the heart-type fatty acid-binding protein and the Pulmonary Embolism Severity Index in patients with acute pulmonary embolism in the emergency department. Acad Emerg Med. 2014 Oct ;21(10):1143-50.

Le Moigne M, Sommet A, Lapeyre-Mestre M, Bourrel R, Molinier L, Paul C, Montastruc JL. Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis : a cohort analysis in the French insurance database. J Eur Acad Dermatol Venereol. 2014 ;28 :1235-44.

Loulergue P, Tubach F, Salmon D, Della monica P, Taillan B, Thorel JB, Marteau P, Bressot C, Ravaud P, Mariette X, Lortholary O, for the RATIO Group. Bacteremia in patients receiving TNF-alpha antagonists - a prospective multicenter study. Journal of Infection. 2013 ;67:524-8 (publié en 2014).

Néel A, Henry B, Barbarot S, Masseau A, Perrin F, Bernier C, Kyndt X, Puechal X, Weiller PJ, Decaux O, Ninet J, Hot A, Aouba A, Astudillo L, Berthelot JM, Bonnet F, Brisseau JM, Cador B, Closs-Prophette F, Dejoie T, de Korwin JD, Dhote R, Fior R, Grosbois B, Hachulla E, Hatron PY, Jardel H, Launay D, Lorleac’h A, Pottier P, Moulis G, Serratrice J, Smail A, Hamidou M. Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler’s syndrome : a French multicenter study. Autoimmun Rev. 2014 Oct ;13(10):1035-41.

Pages A, Bondon-Guitton E, Montastruc JL, Bagheri H. Undesirable effects related to oral antineoplastic drugs : comparison between patients’ internet narratives and a national pharmacovigilance database. Drug Saf.
2014 ;37:629-37.

Paricaud K, Moulis G, Combis MS, Sailler L, Arlet P. Causes of protidemia above 100g/L. Eur J Intern Med. 2014 Dec ;25(10):e123

Hurault Delarue C, Montastruc JL, Beau AB, Lacroix I, Damase-Michel C. Pregnancy outcome in women exposed to, dopamine agonists during pregnancy : a pharmacoepidemiology study in EFEMERIS database. Arch Gynecol Obstet. 2014 ;290(2):263-70

Charlton RA, Neville AJ, Jordan S, Pierini A, Damase-Michel C, Klungsoyr K, Nybo Andersen AM, Vinkel Habsen A, Gini R, Bos JHJ, Puccini A, Hurault-Delarue C, Brooks CJ, de Jong-Van Den Berg LTW, de Vries CS. Healthcare databases in Europe for study medicine use and safety during pregnancy. Pharmacoepidemiol and Drug Saf. 2014 ;23:586-94.

Beau AB, Hurault-Delarue C, Vial T, Montastruc JL, Damase-Michel C, Lacroix I. Safety of oseltamivir during pregnancy : a comparative study using the EFEMERIS database. BJOG. 2014 ;121:895-900.

Beau AB, Hurault-Delarue C, Vidal S, Guitard C, Vayssière C, Petiot D, Montastruc JL, Damase-Michel C, Lacroix I. Pandemic A/H1N1 influenza vaccination during pregnancy : a comparative study using the EFEMERIS database. Vaccine. 2014 ;32:1254-8.

Damase-Michel C, Lacroix I, Hurault-Delarue C, Beau AB, Montastruc JL. Evaluation des médicaments chez la femme enceinte : à propos de la base de données française EFEMERIS. Thérapie. 2014 ;69:91-100.

Damase-Michel C. Médicaments et consultation préconceptionnelle. In CD du 26e Forum de la Faculté de Médecine Toulouse Rangueil et Purpan le 26 octobre 2014.

Damase-Michel C, Hurault-Delarue C. Ibuprofen does not seem to increase global malformation risk but NSAID use in late pregnancy remains a concern. Evid Based Med. 2014 Apr ;19(2):74.

Abadie D, Chebane L, Bert M, Durrieu G, Montastruc JL. Online reporting of adverse drug reactions : a study from a french regional pharmacovigilance center. Thérapie. 2014 ;69:395-400.

Abadie D. Le syndrome sérotoninergique en pratique. In CD du 26e Forum de la Faculté de Médecine Toulouse Rangueil et Purpan le 26 octobre 2014.

Soussan C, Gouraud A, Portoloan G, Jean-Pastor MJ, Pecriaux C, Montastruc JL, Damase-Michel C. Drug-induced adverse reactions via breastfeeding : a descriptive study in the French pharmacovigilance database. Eur J Clin Pharmacol. 2014 ;70(11):1361-66.

Soussan-Dahan M, Lapeyre-Mestre M, Bondon-Guitton E, Delord JP, Despas F. Cetuximab cutaneous adverse drug reactions : a marker of efficacy for metastatic colorectal cancer and head-neck cancer ?. Thérapie. 2014 Nov-Dec ;69(6):499-507.

Palosse-Cantaloube L, Lacroix I, Rousseau V, Bagheri H, Montastruc JL, Damase-Michel C. Analysis of chats on French internet forums about drugs ad pregnancy. Pharmacoepidemiol and Drug Saf. 2014 ;23(12):1330-3.

Faillie JL, Azoulay L, Patenaude V, Hillaire-Buys D, Suissa S. Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes : cohort study. BMJ. 2014. Apr24 ;348:g2780

Faillie JL, Babai S, Crépin S, Bres V, Laroche ML, Le Louet H, Petit P, Montastruc JL, Hillaire-Buys D. French Pharmacovigilance Centers Network. Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors : a case/non-case study from the French Pharmacovigilance Database. Acta Diabetol. 2014 ;51:491-7.

De Souto Barreto P, Lapeyre-Mestre M, Vellas B, Rolland Y. Multimorbidity type, hospitalizations and emergency department visits among nursing home residents : a preliminary study. J Nutr Health Aging. 2014 Jul ;18(7):705-9.

De Souto Barreto P, Lapeyre-Mestre M, Vellas B, Rolland Y. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011. Vaccine. 2014 Feb 7 ;32(7):846-51.

De Souto Barreto P1, Sanz C, Vellas B, Lapeyre-Mestre M, Rolland Y. Drug treatment for diabetes in nursing home residents. Diabet Med. 2014 May ;31(5):570-6.

De Souto Barreto P, Lapeyre-Mestre M, Vellas B, Rolland Y. From rural to urban areas : differences in behavioural and psychological symptoms of dementia in nursing home residents according to geographical location. Psychogeriatrics. 2014 Dec ;14(4):229-34.

Pochard L, Hauviller L, Cuzin L, Eyvrard F, Sommet A, Montastruc JL, Bagherie H. Apport du logiciel Nadis® dans la collecte des effets indésirables des antirétroviraux : expérience en Midi-Pyrénées. Thérapie. 2014 ;69:149-55.

Vardon F, Bounes V, Ducassé JL, Minville V, Lapostolle F. Out-of-hospital equipment of emergency medical services for hemorrhagic shock management : Can do better !. Ann Fr Anesth Reanim. 2014 Dec ;33(12):621-5.

Sommet A. Génériques : des prescriptions selon la classe. Science et santé. 2014 Jan-fév ;18:36.

Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines : a multinational self-controlled case series in Europe. PLoS One. 2014 Jan 3 ;9(1):e82222.